X4 Pharmaceuticals, Inc.
NASDAQ:XFOR · NASDAQ Capital Market
+$0.12 today
Vol 0.21M · Avg 0.40M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+49.50%
Period High
$4.66
Period Low
$1.42
Latest
$4.10
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Karyopharm Therapeutics Inc.
NASDAQ:KPTI
$215.30M
Mersana Therapeutics, Inc.
MRSN
$145.36M
OnKure Therapeutics, Inc.
NASDAQ:OKUR
$57.43M
Kezar Life Sciences, Inc.
KZR
$53.86M
FibroGen, Inc.
FGEN
$36.69M
INmune Bio, Inc.
INMB
$32.97M
Aligos Therapeutics, Inc.
ALGS
$32.67M
Skye Bioscience, Inc.
SKYE
$27.67M
Senti Biosciences, Inc.
SNTI
$25.24M
Tempest Therapeutics, Inc.
TPST
$5.60M
What is the latest XFOR filing?
The latest filing shown is SC 13G/A dated May 15, 2026.
How many recent filings does XFOR have?
Intrinsic Alpha currently shows 20 recent filings for XFOR.
Explore More
Continue the stock analysis
Jump to another research area for this company.